R Squared’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$672K Sell
560
-2,087
-79% -$2.13M 0.35% 59
2026
Q1
$2.43M Buy
2,647
+2,034
+332% +$2.06M 1.34% 6
2025
Q4
$659K Sell
613
-31
-5% -$29.6K 0.31% 84
2025
Q3
$491K Sell
644
-4
-0.6% -$2.98K 0.21% 138
2025
Q2
$505K Buy
+648
New +$504K 0.28% 104
2025
Q1
Sell
-290
Closed -$224K 949
2024
Q4
$224K Buy
+290
New +$240K 0.22% 92

Other funds holding LLY

R Squared's LLY Position: Q2 2026 in Review

R Squared reduced its Eli Lilly (LLY) stake by 79% in Q2 2026, selling an estimated $2.13M and leaving 560 shares worth $672K. The position accounts for 0.35% of the portfolio, ranked #59.

R Squared first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.43M in Q1 2026. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • R Squared held 560 shares of Eli Lilly worth $672K as of Q2 2026.
  • R Squared sold 2,087 Eli Lilly shares in Q2 2026, an estimated $2.13M.
  • Eli Lilly made up 0.35% of R Squared's portfolio in Q2 2026, its #59 holding.
  • R Squared first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • R Squared's Eli Lilly position peaked at $2.43M in Q1 2026.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.